These effects reveal that ginsenoside Rb1 may exert double-cardioprotective effects on both MI/R injury in diabetes and diabetic damage due to MI/R, partly by inhibiting oxidative stress and apoptosis, enhancing the eNOS expression, and increasing the NO concentration, as well as activating the PI3K/Akt pathway. This evidence concerns the gene AKT1 and diabetes mellitus.